RWA Wealth Partners’s Boston Scientific BSX Stock Holding History

RWA Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Sell	5,653 -356	-6%	-$19.3K	﹤0.01%	601
2026 Q1	$377K	Sell	6,009 -40	-0.7%	-$3.2K	﹤0.01%	497
2025 Q4	$577K	Buy	6,049 +79	+1%	+$7.75K	0.01%	418
2025 Q3	$583K	Buy	5,970 +250	+4%	+$25.9K	0.01%	417
2025 Q2	$614K	Hold	5,720	–	–	0.01%	398
2025 Q1	$577K	Sell	5,720 -265	-4%	-$26.7K	0.01%	392
2024 Q4	$535K	Buy	5,985 +33	+0.6%	+$2.9K	0.01%	406
2024 Q3	$499K	Buy	5,952 +3,039	+104%	+$240K	0.01%	402
2024 Q2	$224K	Buy	+2,913	New	+$213K	﹤0.01%	513
2018 Q3	–	Sell	-57	Closed	-$2K	–	292
2018 Q2	$2K	Hold	57	–	–	﹤0.01%	744
2018 Q1	$2K	Buy	+57	New	+$1.55K	﹤0.01%	544

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RWA Wealth Partners's BSX Position: Q2 2026 in Review

RWA Wealth Partners reduced its Boston Scientific (BSX) stake by 5.9% in Q2 2026, selling an estimated $19.3K and leaving 5,653 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

RWA Wealth Partners first reported a position in BSX in Q1 2018 and has held it in 11 quarters since. The position peaked at $614K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

RWA Wealth Partners held 5,653 shares of Boston Scientific worth $241K as of Q2 2026.
RWA Wealth Partners sold 356 Boston Scientific shares in Q2 2026, an estimated $19.3K.
Boston Scientific made up ﹤0.01% of RWA Wealth Partners's portfolio in Q2 2026, its #601 holding.
RWA Wealth Partners first reported a position in Boston Scientific in Q1 2018 and has held it in 11 quarters since.
RWA Wealth Partners's Boston Scientific position peaked at $614K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.